1. Home
  2. ILMN vs SBAC Comparison

ILMN vs SBAC Comparison

Compare ILMN & SBAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • SBAC
  • Stock Information
  • Founded
  • ILMN 1998
  • SBAC 1989
  • Country
  • ILMN United States
  • SBAC United States
  • Employees
  • ILMN N/A
  • SBAC N/A
  • Industry
  • ILMN Medical Specialities
  • SBAC Real Estate Investment Trusts
  • Sector
  • ILMN Health Care
  • SBAC Real Estate
  • Exchange
  • ILMN Nasdaq
  • SBAC Nasdaq
  • Market Cap
  • ILMN 15.3B
  • SBAC 20.2B
  • IPO Year
  • ILMN 2000
  • SBAC 1999
  • Fundamental
  • Price
  • ILMN $117.64
  • SBAC $190.60
  • Analyst Decision
  • ILMN Hold
  • SBAC Buy
  • Analyst Count
  • ILMN 14
  • SBAC 15
  • Target Price
  • ILMN $120.29
  • SBAC $244.13
  • AVG Volume (30 Days)
  • ILMN 1.6M
  • SBAC 1.1M
  • Earning Date
  • ILMN 10-30-2025
  • SBAC 11-03-2025
  • Dividend Yield
  • ILMN N/A
  • SBAC 2.32%
  • EPS Growth
  • ILMN N/A
  • SBAC 71.76
  • EPS
  • ILMN 4.46
  • SBAC 8.15
  • Revenue
  • ILMN $4,288,000,000.00
  • SBAC $2,724,524,000.00
  • Revenue This Year
  • ILMN N/A
  • SBAC $6.84
  • Revenue Next Year
  • ILMN $2.74
  • SBAC $2.41
  • P/E Ratio
  • ILMN $22.20
  • SBAC $23.45
  • Revenue Growth
  • ILMN N/A
  • SBAC 1.82
  • 52 Week Low
  • ILMN $68.70
  • SBAC $185.45
  • 52 Week High
  • ILMN $156.66
  • SBAC $245.16
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 71.13
  • SBAC 38.95
  • Support Level
  • ILMN $94.00
  • SBAC $187.53
  • Resistance Level
  • ILMN $101.93
  • SBAC $194.19
  • Average True Range (ATR)
  • ILMN 4.44
  • SBAC 4.29
  • MACD
  • ILMN 1.42
  • SBAC 0.07
  • Stochastic Oscillator
  • ILMN 100.00
  • SBAC 24.75

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About SBAC SBA Communications Corporation

SBA Communications owns a portfolio of about 45,000 wireless towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, who install equipment to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by the top few mobile carriers. It owns more than 17,000 towers in the US, which account for about 75% of leasing revenue. Internationally, SBA's largest presence is in Brazil, where it owns roughly 10,000 towers. SBA operates as a real estate investment trust.

Share on Social Networks: